BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 306 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2024. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 114,600 | $12,351,588 | 11.91% |
Rock Springs Capital Management LP | 2,460,417 | $265,183,744 | 7.98% |
Ally Bridge Group (NY) LLC | 75,638 | $8,152,264 | 4.86% |
Orion Investment Co | 108,790 | $11,725,386 | 4.67% |
Integral Health Asset Management, LLC | 340,000 | $36,645,200 | 3.48% |
First Turn Management, LLC | 184,901 | $19,928,630 | 3.24% |
DAFNA Capital Management LLC | 104,763 | $11,291,356 | 2.70% |
Casdin Capital, LLC | 326,378 | $35,177,021 | 2.70% |
Avidity Partners Management LP | 383,000 | $41,279,740 | 1.75% |
EMERALD MUTUAL FUND ADVISERS TRUST | 278,333 | $29,998,731 | 1.57% |
EMERALD ADVISERS, LLC | 341,200 | $36,774,536 | 1.54% |
Ghost Tree Capital, LLC | 40,000 | $4,311,200 | 1.35% |
Hood River Capital Management LLC | 502,820 | $54,193,940 | 1.12% |
Novo Holdings A/S | 175,000 | $18,861,500 | 1.10% |
NBW CAPITAL LLC | 51,030 | $5,500,013 | 1.08% |
EAM Global Investors LLC | 41,242 | $4,445,063 | 1.00% |
Woodline Partners LP | 880,147 | $94,862,244 | 0.90% |
O'Neil Global Advisors, Inc. | 13,283 | $1,432 | 0.67% |
Redmile Group, LLC | 94,405 | $10,174,971 | 0.62% |
Granahan Investment Management | 139,732 | $15,060,315 | 0.60% |
External links
This page lists BLUEPRINT MEDICINES CORP's shareholders in Q2 2024. To view BLUEPRINT MEDICINES CORP's shareholder history, click here.